相关实验视频
Updated: Jun 12, 2026

05:53
Use of a Hanging-weight System for Liver Ischemia in Mice
Published on: August 7, 2012
16.5K
DRP1的枯竭保护NK细胞免受低氧引起的功能障碍
Tias Verhezen1, Astrid Van Den Eynde1, Peter Verstraelen2
1Center for Oncological Research (CORE), Integrated Precision and Personalized Oncology Network (IPPON), University of Antwerp, Antwerpen, Belgium.
Redox report : communications in free radical research
|February 18, 2026
概括
缺氧会损害固体瘤中的自然杀手 (NK) 细胞功能. 无活化DRP1蛋白在低氧条件下恢复NK细胞线粒体和细胞毒性活动,增强CAR-NK细胞的疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 细胞疗法在固体瘤中表现出有限的疗效,主要是由于免疫抑制性瘤微环境.
- 瘤缺氧显著损害自然杀手 (NK) 细胞功能,这是对抗癌症天生的免疫力的关键组成部分.
研究的目的:
- 为了研究低氧对NK细胞功能的影响.
- 评估在低氧条件下恢复NK细胞活动的策略.
主要方法:
- 培养NK细胞 (无武器或CAR工程) 在normoxia或hypoxia中进行.
- 分析了线粒体功能,ROS生产和基因表达.
- 对癌细胞系和患者衍生器官进行了细胞毒性测定.
- DRP1功能通过药理抑制或CRISPR-Cas9淘汰来调节.
主要成果:
- 缺氧降低了NK细胞的线粒体含量和膜潜力,增加了ROS和改变了基因表达.
- 细胞毒性活性显著受损,即使使用CAR工程.
- 在低氧条件下,DRP1抑制或淘汰恢复了线粒体功能,并保持了NK细胞细胞毒性.
- DRP1淘汰赛CAR NK细胞在低氧条件下保持了对癌症细胞系的有效性.
结论:
- DRP1无活化是一种可行的策略,可以在低氧瘤微环境中增强NK细胞功能.
- 针对DRP1的代谢工程方法可能会改善固体瘤的CAR-NK细胞疗法.
相关概念视频
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Directing Proteins to the Rough Endoplasmic Reticulum
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
The Unfolded Protein Response
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...

